Paper 83 - PHASE 1 STUDY OF INTRATUMORAL BO-112 AND NIVOLUMAB IN RESECTABLE SOFT TISSUE SARCOMA UNDERGOING HYPOFRACTIONATED PREOPERATIVE RADIOTHERAPY

Co-Author(s)

• JD

  Jie Deng, MD PhD

  UCLA
  Los Angeles, California, United States
• AP

  Aastha Pal, MS

  Bioinformatician
  Stanford University
  Mountain View, California, United States
• KC

  Katie Campbell, PhD

  UCLA
  Los Angeles, California, United States
• SC

  Scott C. Chin, BS (he/him/his)

  Research Associate
  UCLA
  Los Angeles, California, United States
• SK

  Sarah Kremer, BS

  UCLA
  Los Angeles, California, United States
• MT

  Mito Tariveranmoshabad, BS

  UCLA
  Los Angeles, California, United States
• AS

  Ajay Subramanian, BS

  Stanford University
  Stanford, California, United States
• MM

  Magdalena Matusiak, PhD

  Stanford
  Stanford, California, United States
• Mv

  Matt van de Rijn, MD, PhD

  SABINE KOHLER, MD, PROFESSOR OF PATHOLOGY
  Stanford University
  Stanford, California, United States
• VR

  Vishruth Reddy, MD PhD

  UCLA
  Los Angeles, California, United States
• CF

  Carol Felix, RN

  UCLA
  Los Angeles, California, United States
• VB

  Vincent Basehart, BS

  UCLA
  Los Angeles, California, United States
• SD

  Sarah Dry, MD

  UCLA
  Los Angeles, California, United States
• SN

  Scott Nelson, MD

  UCLA
  Los Angeles, California, United States
• BC

  Bartosz Chmielowski, MD PhD

  UCLA
  Los Angeles, California, United States
• LS

  Leanne Seeger, MD

  UCLA
  Los Angeles, California, United States
• BL

  Ben Levine, MD

  UCLA
  Los Angeles, California, United States
• KM

  Kambiz Motamedi, MD

  UCLA
  Los Angeles, California, United States
• VG

  Varand Ghazikhanian, MD

  UCLA
  Los Angeles, California, United States
• AS

  Arun S. Singh, MD

  Oncologist
  University of California at Los Angeles
  Santa Monica, California, United States
• NB

  Nicholas M. Bernthal, MD

  University of California Los Angeles
  Los Angeles, California, United States
• JC

  Joseph Crompton, MD PhD

  UCLA
  Los Angeles, California, United States
• MQ

  Marisol Quintero, PhD

  Highlight Therapeutics
  Madrid, Madrid, Spain
• FE

  Fritz Eilber, MD

  UCLA
  Los Angeles, California, United States
• 

  Everett J. Moding, MD, PhD (he/him/his)

  Assistant Professor
  Stanford University
  Stanford, California, United States

Author(s)

• 

  Anusha Kalbasi, MD

  ASSOCIATE PROFESSOR OF RADIATION ONCOLOGY
  Stanford University
  Stanford, California, United States

Co-Author(s)

• ST

  Stefano Testa, MD

  Clinical Fellow in Hematology and Oncology
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States